The Possible Role of PET Imaging Toward Individualized Management of Bone and Soft Tissue Malignancies.
This article presents fluorodeoxyglucose PET/computed tomography for the evaluation of soft tissue sarcomas. Its clinical impact is discussed analyzing all the clinical information provided when applied in different phases of the disease. A special paragraph is dedicated to the use of functional imaging for driving the biopsy.
Nuclear Medicine, AOU di Bologna Policlinico S. Orsola-Malpighi, Via Massarenti 9, Bologna 40138, Italy.
Elena
E
Tabacchi
Nuclear Medicine, AOU di Bologna Policlinico S. Orsola-Malpighi, Via Massarenti 9, Bologna 40138, Italy.
Stefano
S
Fanti
Nuclear Medicine, AOU di Bologna Policlinico S. Orsola-Malpighi, Via Massarenti 9, Bologna 40138, Italy. Electronic address: cristina.nanni@aosp.bo.it.
Cristina
C
Nanni
D001859:Bone Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D057285:Precision Medicine / Q000379:methods*; D012983:Soft Tissue Neoplasms / Q000000981:diagnostic imaging*
Bone; Cancer; Musculoskeletal; Sarcoma; Soft tissue